solid
organ
transplant
recipi
sotr
risk
seriou
influenzarel
complic
impact
respiratori
coinfect
sotr
pandem
influenza
unknown
multicentr
prospect
studi
consecut
case
pandem
influenza
sotr
carri
assess
clinic
characterist
outcom
risk
factor
coinfect
overal
patient
includ
median
time
transplant
year
case
occur
periop
hospitalacquir
pneumonia
diagnos
patient
ten
case
sever
admit
intens
care
unit
suffer
septic
shock
develop
acut
graft
reject
die
coinfect
detect
patient
eight
viral
six
bacteri
one
fungal
viral
coinfect
affect
outcom
patient
nonvir
coinfect
wors
outcom
longer
hospit
stay
vs
higher
rate
sever
diseas
vs
mortal
vs
independ
risk
factor
nonvir
coinfect
diabet
mellitu
septic
shock
factor
associ
sever
influenza
delay
antivir
therapi
diabet
mellitu
time
sinc
transplant
day
pneumonia
conclus
pandem
influenza
caus
signific
direct
indirect
effect
sotr
especi
earli
posttranspl
period
treat
earli
clinician
awar
possibl
nonvir
coinfect
mainli
diabet
patient
sever
case
effort
made
prevent
influenza
immun
patient
environ
new
pandem
influenza
viru
detect
propag
throughout
world
although
sever
pandem
influenza
detect
younger
patient
compar
season
influenza
case
occur
immunosuppress
patient
set
solid
organ
transplant
recipi
sotr
includ
among
risk
group
receiv
pandem
vaccin
given
relat
direct
indirect
morbid
season
influenza
popul
recent
retrospect
studi
describ
demograph
clinic
characterist
prognost
factor
intens
care
unit
icu
admiss
death
adult
children
influenza
organ
transplant
author
small
seri
observ
longer
durat
symptom
higher
frequenc
pneumonia
higher
mortal
rate
gener
popul
influenza
viral
infect
known
predispos
subsequ
lung
bacteri
superinfect
initi
descript
sever
case
pandem
influenza
show
evid
primari
viral
pneumonia
poor
relev
bacteri
coinfect
howev
later
studi
use
pcr
immunochemistri
method
bacteri
coinfect
found
fatal
case
previou
studi
sotr
describ
viral
bacteri
coinfect
impact
prognosi
clinic
care
influenza
analyz
aim
studi
prospect
assess
clinic
characterist
outcom
pandem
influenza
infect
sotr
risk
factor
coinfect
pathogen
prospect
observ
studi
conduct
nine
teach
hospit
belong
spanish
network
research
infecti
diseas
reipi
sotr
older
year
diagnos
influenza
hospit
particip
centr
june
januari
includ
confirm
case
defin
presenc
influenzalik
ill
laboratoryconfirm
pandem
influenza
viru
infect
studi
approv
coordin
local
ethic
committe
inform
consent
obtain
subject
case
respiratori
symptom
sotr
advis
seek
care
hospit
thereaft
investig
evalu
follow
cure
death
case
influenza
diagnosi
clinic
data
record
standard
protocol
data
collect
demograph
characterist
comorbid
bodi
mass
index
bmi
type
transplant
immunosuppress
therapi
previou
vaccin
clinic
sign
symptom
biochem
analysi
chest
xray
find
antivir
antibacteri
therapi
concomit
andor
secondari
infect
outcom
includ
mortal
pandem
influenza
confirm
rtpcr
inf
detect
roch
basel
switzerland
naspopharyng
smear
aspir
blood
cultur
standard
studi
bacteri
fungi
respiratori
sampl
sputum
bronchial
aspir
bronchoalveolar
lavag
protect
specimen
brush
transbronchi
biopsi
urinari
antigen
test
streptococcu
pneumonia
legionella
pneumophila
serogroup
perform
sputum
sampl
process
contain
polymorphonuclear
epitheli
cell
per
highpow
field
viral
coinfect
investig
nasopharyng
sampl
use
pcr
multiplex
rv
ace
detect
seeplex
kit
seegen
inc
seul
corea
includ
metapneumoviru
adenoviru
coronaviru
parainfluenza
viru
rhinoviru
ab
respiratori
syncyti
virus
rsv
ab
influenza
viru
ab
obes
defin
bmi
hospitalacquir
influenza
consid
symptom
began
day
admiss
pneumonia
defin
presenc
clinic
symptom
fever
dyspnoea
cough
andor
expector
new
pulmonari
infiltr
chest
xray
noninfecti
caus
exclud
sever
pneumonia
assess
psi
score
nonvir
coinfect
consid
bacteria
fungi
isol
blood
respiratori
sampl
posit
urinari
antigen
detect
test
pneumonia
l
pneumophila
sever
infect
defin
case
admit
icu
develop
graft
reject
die
descript
analysi
perform
continu
variabl
express
median
rang
proport
calcul
percentag
patient
avail
data
chisquar
fisher
exact
test
use
categor
variabl
studentt
mannwhitney
wilcoxon
test
continu
variabl
appropri
multivari
logist
regress
analysi
factor
potenti
associ
nonvir
coinfect
includ
signific
variabl
univari
analys
clinic
relev
variabl
statist
signific
establish
p
twotail
spss
softwar
version
spss
inc
chicago
il
usa
use
fiftyon
sotr
median
age
year
includ
men
diagnos
influenza
type
transplant
kidney
liver
eight
lung
five
heart
two
combin
pancreaskidney
one
combin
liverkidney
patient
receiv
tripl
therapi
tacrolimu
mycophenol
mofetil
steroid
one
patient
allograft
reject
treat
corticosteroid
bolu
month
prior
influenza
influenza
occur
year
transplant
day
year
case
occur
beyond
first
year
fig
three
patient
symptom
start
day
transplant
without
identif
sourc
influenza
infect
pneumonia
one
die
anoth
lost
graft
acut
reject
four
case
hospit
acquir
comorbid
vaccin
histori
previou
use
antibiot
detail
tabl
one
patient
receiv
pandem
influenza
vaccin
normal
gammaglobulin
level
prior
reject
episod
common
symptom
fever
cough
median
delay
onset
symptom
diagnosi
day
pneumonia
occur
patient
sever
pneumonia
assess
admiss
median
psi
median
score
three
two
patient
septic
shock
cardiac
failur
respect
main
clinic
manifest
radiolog
analyt
find
detail
tabl
diagnosi
laboratori
find
differ
previou
basal
valu
lymphocyt
platelet
count
vs
p
vs
p
respect
median
durat
fever
cough
day
day
respect
median
length
hospit
stay
day
patient
influenza
infect
sever
tabl
seven
patient
requir
admiss
icu
median
day
four
patient
die
two
die
day
influenza
diagnosi
septic
shock
aureu
bacteraem
pneumonia
viridan
empyema
respect
kidney
recipi
patient
die
pulmonari
aspergillosi
day
influenza
fourth
patient
kidney
recipi
pneumococc
bacteraem
pneumonia
day
influenza
diagnosi
escherichia
coli
pneumonia
day
influenza
three
patient
allograft
reject
month
follow
influenza
diagnosi
pancrea
recipi
kidney
recipi
transplant
month
ago
respect
respond
corticosteroid
bolu
liver
recipi
lost
graft
immunosuppress
reduc
patient
influenza
diagnosi
factor
relat
sever
influenza
detail
tabl
predictor
observ
term
underli
diseas
previou
reject
immunosuppress
therapi
type
calcineurin
inhibitor
steroid
induct
therapi
type
organ
clinic
manifest
patient
nonvir
coinfect
longer
hospit
stay
vs
p
higher
rate
sever
diseas
vs
rr
ci
p
mortal
vs
rr
ci
p
presenc
viral
coinfect
influenc
outcom
present
studi
show
onethird
sotr
pandem
influenza
pneumonia
mortal
higher
gener
popul
influenza
infect
sever
patient
recent
transplant
delay
onset
antivir
therapi
among
factor
besid
influenza
may
associ
acut
allograft
reject
coinfect
common
sotr
nonvir
coinfect
associ
wors
outcom
diabet
mellitu
septic
shock
associ
nonvir
coinfect
emerg
pandem
influenza
viru
rais
import
question
regard
impact
transplant
popul
expect
high
associ
morbid
mortal
confirm
studi
season
influenza
occur
time
transplant
vilchez
et
al
observ
median
time
sinc
transplant
month
earliest
case
occur
month
transplant
sotr
season
influenza
case
influenza
data
studi
show
may
occur
time
transplant
median
time
month
moreov
present
prospect
studi
show
case
occur
first
week
transplant
associ
poor
prognosi
thu
two
three
patient
lost
graft
die
respect
studi
suggest
season
influenza
sever
mortal
increas
among
transplant
recipi
earli
posttranspl
period
studi
pandem
influenza
sort
report
data
regard
aspect
present
studi
observ
time
sinc
transplant
shorter
month
associ
sever
hospitalacquir
season
influenza
sotr
document
within
recent
pandem
hospitalacquir
case
influenza
report
immunocompromis
patient
isol
case
describ
sotr
way
found
pandem
influenza
case
hospitalacquir
hospitalacquir
influenza
infect
sotr
even
earli
postop
period
advers
outcom
case
occur
within
first
month
transplant
prompt
consider
first
earli
influenza
diagnosi
treatment
consid
presenc
influenzalik
symptom
especi
case
pneumonia
pandem
season
influenza
period
even
immedi
posttranspl
period
secondli
patient
consid
highrisk
popul
therefor
measur
avoid
inhospit
transmiss
rigor
implement
infect
control
measur
isol
infect
patient
avoid
contact
symptomat
caregiv
sens
necessari
increas
rate
vaccin
among
sotr
close
contact
confer
indirect
protect
nonrespond
vaccin
present
studi
found
symptom
sign
similar
describ
gener
popul
moreov
sotr
pandem
influenza
show
frequent
haematolog
biochem
abnorm
renal
failur
mild
hepatolysi
anaemia
present
influenza
infect
might
possibl
associ
transplant
concomit
immunosuppress
drug
howev
other
lymphopenia
thrombocytopenia
significantli
worsen
influenza
transplant
recipi
season
influenzarel
complic
gener
popul
includ
primari
viral
secondari
bacteri
pneumonia
proport
pneumonia
cohort
report
rang
sotr
respect
sever
pneumonia
admiss
three
four
case
die
psi
risk
class
iv
v
accordingli
score
patient
limit
reduc
number
patient
data
suggest
use
sever
score
pneumonia
pandem
influenza
gener
popul
delay
hospit
admiss
antivir
therapi
associ
unfavour
outcom
present
studi
time
antivir
therapi
also
associ
sever
influenza
modifi
prognost
factor
data
agre
retrospect
studi
show
delay
antivir
therapi
associ
intens
care
unit
admiss
mortal
must
note
patient
includ
receiv
antivir
therapi
within
h
onset
symptom
mani
virolog
confirm
might
contribut
improv
outcom
bacteri
pneumonia
known
complic
influenza
present
studi
patient
nonvir
coinfect
contrast
viral
coinfect
experienc
wors
outcom
despit
earli
antibacteri
therapi
risk
factor
nonvir
coinfect
patient
pandem
influenza
previous
describ
studi
two
associ
factor
influenza
diagnosi
identifi
diabet
mellitu
septic
shock
hand
nonvir
coinfect
diagnos
mild
case
without
pneumonia
find
may
suggest
nonsever
case
could
manag
without
antibacteri
therapi
reduc
number
patient
expos
antibiot
case
twothird
patient
data
subject
sever
limit
first
studi
carri
gener
popul
data
hospit
patient
pandem
influenza
howev
offer
inform
regard
ill
transplant
patient
sever
diseas
need
hospit
admiss
second
suscept
oseltamivir
perform
could
conclud
whether
fatal
case
relat
oseltamivir
resist
third
possibl
graft
reject
histolog
evalu
clinic
evid
could
lead
misdiagnos
mild
allograft
reject
summari
find
indic
pandem
influenza
caus
signific
direct
morbid
mortal
sotr
especi
earli
posttranspl
period
also
indirect
effect
possibl
devast
consequ
graft
function
clinician
awar
possibl
nonvir
coinfect
patient
mainli
diabet
patient
sever
case
effort
made
increas
vaccin
among
sotr
caregiv
